Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

2 recalls, newest first

Class I · High risk

Umovy Acido Hialuronico

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.

Completed Chemical / undeclared Umary-USA.com D-0493-2025
Class I · High risk

Unavy Acido Hialuronico

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

Completed Chemical / undeclared Umary-USA.com D-0492-2025

Recalls by year